{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,21]],"date-time":"2026-10-21T17:17:24Z","timestamp":1792603044997,"version":"4.5.0"},"reference-count":179,"publisher":"Ovid Technologies (Wolters Kluwer Health)","issue":"5","license":[{"start":{"date-parts":[[2026,3,5]],"date-time":"2026-03-05T00:00:00Z","timestamp":1772668800000},"content-version":"unspecified","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0\/"}],"content-domain":{"domain":["lww.com","ovid.com"],"crossmark-restriction":true},"short-container-title":[],"published-print":{"date-parts":[[2026,3,5]]},"abstract":"<jats:sec>\n                    <jats:title>Abstract<\/jats:title>\n                    <jats:p>Leucine-rich repeat kinase 2 (LRRK2) is a critical target for the treatment of Parkinson\u2019s disease (PD) and potentially other diseases. LRRK2 is involved in intracellular signaling, immune response, and inflammation, with key roles in both the central nervous system and peripheral tissues. LRRK2 mutations are linked to cellular dysfunction including mitochondrial and neuronal damage and can disrupt signaling pathway balance, thereby contributing to PD and other disorders. Inhibiting LRRK2 kinase activity shows potential for treating PD by correcting cellular imbalances and reducing neuronal damage. However, risks associated with regulating a multifunctional protein must be addressed. Further research on the molecular partners and tissue-specific functions of LRRK2 is essential for developing targeted therapies and improving treatment options for related diseases. This review offers a comprehensive analysis of LRRK2, with a focus on its physiological functions, disease involvement, and emerging therapeutic strategies.<\/jats:p>\n                  <\/jats:sec>","DOI":"10.1097\/cm9.0000000000003989","type":"journal-article","created":{"date-parts":[[2026,3,5]],"date-time":"2026-03-05T05:00:42Z","timestamp":1772686842000},"page":"653-671","update-policy":"https:\/\/doi.org\/10.1097\/lww.0000000000001000","source":"Crossref","is-referenced-by-count":5,"title":["Role of LRRK2 in physiological activities, diseases, and therapy"],"prefix":"10.1097","volume":"139","author":[{"given":"Zhuoran","family":"Wang","sequence":"first","affiliation":[{"name":"Department of Biotherapy, Cancer Center, West China Hospital, Sichuan University, Chengdu, Sichuan 610041, China"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Qingfang","family":"Li","sequence":"additional","affiliation":[{"name":"Department of Biotherapy, Cancer Center, West China Hospital, Sichuan University, Chengdu, Sichuan 610041, China"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Lingxi","family":"Yan","sequence":"additional","affiliation":[{"name":"Department of Biotherapy, Cancer Center, West China Hospital, Sichuan University, Chengdu, Sichuan 610041, China"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Mingyu","family":"Du","sequence":"additional","affiliation":[{"name":"Department of Biotherapy, Cancer Center, West China Hospital, Sichuan University, Chengdu, Sichuan 610041, China"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Xiawei","family":"Wei","sequence":"additional","affiliation":[{"name":"Department of Biotherapy, Cancer Center, West China Hospital, Sichuan University, Chengdu, Sichuan 610041, China"}],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"276","published-online":{"date-parts":[[2026,3,5]]},"reference":[{"key":"R1-20260305","doi-asserted-by":"crossref","first-page":"601","DOI":"10.1016\/j.neuron.2004.11.005","article-title":"Mutations in LRRK2 cause autosomal-dominant Parkinsonism with pleomorphic pathology","volume":"44","author":"Zimprich","year":"2004","journal-title":"Neuron"},{"key":"R2-20260305","doi-asserted-by":"crossref","first-page":"546","DOI":"10.1038\/s41594-021-00628-z","article-title":"Seeing the bigger picture: First full-length human LRRK2 structures","volume":"28","author":"Ullrich","year":"2021","journal-title":"Nature Structural & Molecular Biology"},{"key":"R3-20260305","doi-asserted-by":"crossref","first-page":"16906","DOI":"10.1074\/jbc.M708718200","article-title":"The Parkinson disease-associated leucine-rich repeat kinase 2 (LRRK2) is a dimer that undergoes intramolecular autophosphorylation","volume":"283","author":"Greggio","year":"2008","journal-title":"Journal of Biological Chemistry"},{"key":"R4-20260305","doi-asserted-by":"crossref","first-page":"890","DOI":"10.1093\/hmg\/ddr526","article-title":"LRRK2 Parkinson disease mutations enhance its microtubule association","volume":"21","author":"Kett","year":"2012","journal-title":"Human Molecular Genetics"},{"key":"R5-20260305","doi-asserted-by":"crossref","first-page":"953","DOI":"10.1097\/01.jnen.0000235121.98052.54","article-title":"LRRK2 expression in normal and pathologic human brain and in human cell lines","volume":"65","author":"Miklossy","year":"2006","journal-title":"Journal of Neuropathology and Experimental Neurology"},{"key":"R6-20260305","doi-asserted-by":"crossref","first-page":"104","DOI":"10.1038\/s41531-023-00544-7","article-title":"Perspective on the current state of the LRRK2 field","volume":"9","author":"Taymans","year":"2023","journal-title":"npj Parkinson\u2019s Disease"},{"key":"R7-20260305","doi-asserted-by":"crossref","DOI":"10.1016\/j.redox.2023.102860","article-title":"LRRK2 aggravates kidney injury through promoting MFN2 degradation and abnormal mitochondrial integrity","volume":"66","author":"Zhang","year":"2023","journal-title":"Redox Biology"},{"key":"R8-20260305","doi-asserted-by":"crossref","first-page":"4209","DOI":"10.1093\/hmg\/ddr348","article-title":"LRRK2 protein levels are determined by kinase function and are crucial for kidney and lung homeostasis in mice","volume":"20","author":"Herzig","year":"2011","journal-title":"Human Molecular Genetics"},{"key":"R9-20260305","doi-asserted-by":"crossref","DOI":"10.1016\/j.brainres.2021.147503","article-title":"In silico comparative analysis of LRRK2 interactomes from brain, kidney and lung","volume":"1765","author":"Verma","year":"2021","journal-title":"Brain Research"},{"key":"R10-20260305","doi-asserted-by":"crossref","first-page":"1581","DOI":"10.1042\/BST20180463","article-title":"LRRK2 regulation of immune-pathways and inflammatory disease","volume":"47","author":"Wallings","year":"2019","journal-title":"Biochemical Society Transactions"},{"key":"R11-20260305","doi-asserted-by":"crossref","DOI":"10.1002\/brb3.2886","article-title":"In vivo overexpression of synaptogyrin-3 promotes striatal synaptic dopamine uptake in LRRK2R1441G mutant mouse model of Parkinson\u2019s disease","volume":"13","author":"Ho","year":"2023","journal-title":"Brain and Behavior"},{"key":"R12-20260305","doi-asserted-by":"crossref","first-page":"4738","DOI":"10.1074\/jbc.RA118.005008","article-title":"The G2019S variant of leucine-rich repeat kinase 2 (LRRK2) alters endolysosomal trafficking by impairing the function of the GTPase RAB8A","volume":"294","author":"Rivero-R\u00edos","year":"2019","journal-title":"Journal of Biological Chemistry"},{"key":"R13-20260305","doi-asserted-by":"crossref","first-page":"133","DOI":"10.1080\/21541248.2019.1666623","article-title":"LRRK2 binds to the Rab32 subfamily in a GTP-dependent manner via its armadillo domain","volume":"12","author":"McGrath","year":"2019","journal-title":"Small GTPases"},{"key":"R14-20260305","doi-asserted-by":"crossref","first-page":"1","DOI":"10.15252\/embj.201798099","article-title":"Rab29 activation of the Parkinson\u2019s disease-associated LRRK2 kinase","volume":"37","author":"Purlyte","year":"2017","journal-title":"The EMBO Journal"},{"key":"R15-20260305","doi-asserted-by":"crossref","DOI":"10.1016\/j.nbd.2022.105769","article-title":"Directing LRRK2 to membranes of the endolysosomal pathway triggers RAB phosphorylation and JIP4 recruitment","volume":"170","author":"Kluss","year":"2022","journal-title":"Neurobiology of Disease"},{"key":"R16-20260305","doi-asserted-by":"crossref","first-page":"223","DOI":"10.1093\/hmg\/ddi439","article-title":"The Parkinson disease causing LRRK2 mutation I2020T is associated with increased kinase activity","volume":"15","author":"Gloeckner","year":"2006","journal-title":"Hum Mol Genet"},{"key":"R17-20260305","doi-asserted-by":"crossref","first-page":"2031","DOI":"10.1093\/hmg\/ddm151","article-title":"Mechanistic insight into the dominant mode of the Parkinson\u2019s disease-associated G2019S LRRK2 mutation","volume":"16","author":"Luz\u00f3n-Toro","year":"2007","journal-title":"Hum Mol Genet"},{"key":"R18-20260305","doi-asserted-by":"crossref","first-page":"4022","DOI":"10.1093\/hmg\/ddp346","article-title":"LRRK2 regulates autophagic activity and localizes to specific membrane microdomains in a novel human genomic reporter cellular model","volume":"18","author":"Alegre-Abarrategui","year":"2009","journal-title":"Human Molecular Genetics"},{"key":"R19-20260305","doi-asserted-by":"crossref","first-page":"45","DOI":"10.1038\/s41420-020-0279-y","article-title":"Kinase inhibition of G2019S-LRRK2 enhances autolysosome formation and function to reduce endogenous alpha-synuclein intracellular inclusions","volume":"6","author":"Obergasteiger","year":"2020","journal-title":"Cell Death Discovery"},{"key":"R20-20260305","doi-asserted-by":"crossref","first-page":"203","DOI":"10.1080\/15548627.2019.1603548","article-title":"LRRK2 mutations impair depolarization-induced mitophagy through inhibition of mitochondrial accumulation of RAB10","volume":"16","author":"Wauters","year":"2019","journal-title":"Autophagy"},{"key":"R21-20260305","doi-asserted-by":"crossref","DOI":"10.1091\/mbc.E22-04-0139","article-title":"The endoplasmic reticulum contributes to lysosomal tubulation\/sorting driven by LRRK2","volume":"33","author":"Bonet-Ponce","year":"2022","journal-title":"Molecular Biology of the Cell"},{"key":"R22-20260305","doi-asserted-by":"crossref","first-page":"4397","DOI":"10.1042\/BCJ20200458","article-title":"Endogenous Rab29 does not impact basal or stimulated LRRK2 pathway activity","volume":"477","author":"Kalogeropulou","year":"2020","journal-title":"Biochemical Journal"},{"key":"R23-20260305","doi-asserted-by":"crossref","first-page":"1719","DOI":"10.3390\/cells9071719","article-title":"Distinct roles for RAB10 and RAB29 in pathogenic LRRK2-mediated endolysosomal trafficking alterations","volume":"9","author":"Rivero-R\u00edos","year":"2020","journal-title":"Cells"},{"key":"R24-20260305","doi-asserted-by":"crossref","DOI":"10.7554\/eLife.12813","article-title":"Phosphoproteomics reveals that Parkinson\u2019s disease kinase LRRK2 regulates a subset of Rab GTPases","volume":"5","author":"Steger","year":"2016","journal-title":"eLife"},{"key":"R25-20260305","doi-asserted-by":"crossref","DOI":"10.1126\/sciadv.adk6191","article-title":"Inhibition of Parkinson\u2019s disease\u2013related LRRK2 by type I and type II kinase inhibitors: Activity and structures","volume":"9","author":"Sanz Murillo","year":"2023","journal-title":"Science Advances"},{"key":"R26-20260305","doi-asserted-by":"crossref","first-page":"1101","DOI":"10.3390\/biom11081101","article-title":"LRRK2 targeting strategies as potential treatment of Parkinson\u2019s disease","volume":"11","author":"Wojewska","year":"2021","journal-title":"Biomolecules"},{"key":"R27-20260305","doi-asserted-by":"crossref","DOI":"10.1126\/scisignal.abg3555","article-title":"Dysregulation of the AP2M1 phosphorylation cycle by LRRK2 impairs endocytosis and leads to dopaminergic neurodegeneration","volume":"14","author":"Liu","year":"2021","journal-title":"Science Signaling"},{"key":"R28-20260305","doi-asserted-by":"crossref","first-page":"1196","DOI":"10.1038\/s41594-022-00863-y","article-title":"Structural basis for Parkinson\u2019s disease-linked LRRK2\u2019s binding to microtubules","volume":"29","author":"Snead","year":"2022","journal-title":"Nature Structural & Molecular Biology"},{"key":"R29-20260305","article-title":"LRRK2 Gly2019Ser mutation promotes ER stress via interacting with THBS1\/TGF-\u03b21 in Parkinson\u2019s disease","volume":"10","author":"Yao","year":"2023","journal-title":"Adv Sci (Weinh)"},{"key":"R30-20260305","doi-asserted-by":"crossref","DOI":"10.1073\/pnas.2303789120","article-title":"LRRK2 suppresses lysosome degradative activity in macrophages and microglia through MiT-TFE transcription factor inhibition","volume":"120","author":"Yadavalli","year":"2023","journal-title":"Proc Natl Acad Sci U S A"},{"key":"R31-20260305","doi-asserted-by":"crossref","DOI":"10.1091\/mbc.E22-04-0139","article-title":"The endoplasmic reticulum contributes to lysosomal tubulation\/sorting driven by LRRK2","volume":"33","author":"Bonet-Ponce","year":"2022","journal-title":"Mol Biol Cell"},{"key":"R32-20260305","doi-asserted-by":"crossref","DOI":"10.1038\/srep29945","article-title":"LRRK2 and RAB7L1 coordinately regulate axonal morphology and lysosome integrity in diverse cellular contexts","volume":"6","author":"Kuwahara","year":"2016","journal-title":"Sci Rep"},{"key":"R33-20260305","doi-asserted-by":"crossref","DOI":"10.1126\/sciadv.abb2454","article-title":"LRRK2 mediates tubulation and vesicle sorting from lysosomes","volume":"6","author":"Bonet-Ponce","year":"2020","journal-title":"Science Advances"},{"key":"R34-20260305","doi-asserted-by":"crossref","first-page":"204","DOI":"10.1080\/15548627.2021.1954779","article-title":"LRRK2 is required for CD38-mediated NAADP-Ca(2+) signaling and the downstream activation of TFEB (transcription factor EB) in immune cells","volume":"18","author":"Nabar","year":"2022","journal-title":"Autophagy"},{"key":"R35-20260305","doi-asserted-by":"crossref","first-page":"1362","DOI":"10.1002\/mds.28490","article-title":"Differential inhibition of LRRK2 in Parkinson\u2019s disease patient blood by a G2019S selective LRRK2 inhibitor","volume":"36","author":"Bright","year":"2021","journal-title":"Movement Disorders"},{"key":"R36-20260305","doi-asserted-by":"crossref","first-page":"1692","DOI":"10.1080\/15548627.2024.2330032","article-title":"CASM mediates LRRK2 recruitment and activation under lysosomal stress","volume":"20","author":"Kuwahara","year":"2024","journal-title":"Autophagy"},{"key":"R37-20260305","doi-asserted-by":"crossref","first-page":"6935","DOI":"10.3390\/ijms23136935","article-title":"Seventy-two-hour LRRK2 kinase activity inhibition increases lysosomal GBA expression in H4, a human neuroglioma cell line","volume":"23","author":"Ruz","year":"2022","journal-title":"Int J Mol Sci"},{"key":"R38-20260305","doi-asserted-by":"crossref","DOI":"10.1073\/pnas.2205492119","article-title":"Lysosomal positioning regulates Rab10 phosphorylation at LRRK2(+) lysosomes","volume":"119","author":"Kluss","year":"2022","journal-title":"Proc Natl Acad Sci U S A"},{"key":"R39-20260305","doi-asserted-by":"crossref","first-page":"E9115","DOI":"10.1073\/pnas.1812196115","article-title":"LRRK2 and its substrate Rab GTPases are sequentially targeted onto stressed lysosomes and maintain their homeostasis","volume":"115","author":"Eguchi","year":"2018","journal-title":"Proc Natl Acad Sci U S A"},{"key":"R40-20260305","doi-asserted-by":"crossref","first-page":"796","DOI":"10.1016\/j.neuron.2017.09.036","article-title":"Age-dependent dopaminergic neurodegeneration and impairment of the autophagy-lysosomal pathway in LRRK-deficient mice","volume":"96","author":"Giaime","year":"2017","journal-title":"Neuron"},{"key":"R41-20260305","doi-asserted-by":"crossref","first-page":"5570","DOI":"10.1038\/s41467-019-13413-w","article-title":"LRRK2 kinase activity regulates lysosomal glucocerebrosidase in neurons derived from Parkinson\u2019s disease patients","volume":"10","author":"Ysselstein","year":"2019","journal-title":"Nature Communications"},{"key":"R42-20260305","doi-asserted-by":"crossref","first-page":"26","DOI":"10.1016\/j.nbd.2017.12.005","article-title":"Familial knockin mutation of LRRK2 causes lysosomal dysfunction and accumulation of endogenous insoluble \u03b1-synuclein in neurons","volume":"111","author":"Schapansky","year":"2018","journal-title":"Neurobiol Dis"},{"key":"R43-20260305","doi-asserted-by":"crossref","first-page":"506","DOI":"10.1111\/tra.12866","article-title":"A LRRK2\/dLRRK-mediated lysosomal pathway that contributes to glial cell death and DA neuron survival","volume":"23","author":"Wang","year":"2022","journal-title":"Traffic"},{"key":"R44-20260305","doi-asserted-by":"crossref","first-page":"2","DOI":"10.1186\/1750-1326-7-2","article-title":"Loss of leucine-rich repeat kinase 2 causes age-dependent bi-phasic alterations of the autophagy pathway","volume":"7","author":"Tong","year":"2012","journal-title":"Mol Neurodegener"},{"key":"R45-20260305","doi-asserted-by":"crossref","first-page":"26","DOI":"10.1186\/s13024-015-0022-y","article-title":"Mutations in LRRK2 potentiate age-related impairment of autophagic flux","volume":"10","author":"Saha","year":"2015","journal-title":"Mol Neurodegener"},{"key":"R46-20260305","doi-asserted-by":"crossref","first-page":"551","DOI":"10.1042\/BST20190236","article-title":"Parkinson\u2019s disease and mitophagy: An emerging role for LRRK2","volume":"49","author":"Singh","year":"2021","journal-title":"Biochem Soc Trans"},{"key":"R47-20260305","doi-asserted-by":"crossref","first-page":"2808","DOI":"10.1093\/hmg\/ddad102","article-title":"Mitochondrial dysfunction and mitophagy defects in LRRK2-R1441C Parkinson\u2019s disease models","volume":"32","author":"Williamson","year":"2023","journal-title":"Hum Mol Genet"},{"key":"R48-20260305","doi-asserted-by":"crossref","first-page":"34","DOI":"10.1016\/j.pharmthera.2015.10.005","article-title":"Parkinson\u2019s disease proteins: Novel mitochondrial targets for cardioprotection","volume":"156","author":"Mukherjee","year":"2015","journal-title":"Pharmacol Ther"},{"key":"R49-20260305","doi-asserted-by":"crossref","first-page":"650","DOI":"10.1111\/j.1471-4159.2012.07809.x","article-title":"Leucine-rich repeat kinase 2 disturbs mitochondrial dynamics via Dynamin-like protein","volume":"122","author":"Niu","year":"2012","journal-title":"J Neurochem"},{"key":"R50-20260305","doi-asserted-by":"crossref","DOI":"10.1038\/cddis.2014.184","article-title":"Mitochondrial dysfunction driven by the LRRK2-mediated pathway is associated with loss of Purkinje cells and motor coordination deficits in diabetic rat model","volume":"5","author":"Yang","year":"2014","journal-title":"Cell Death Dis"},{"key":"R51-20260305","doi-asserted-by":"crossref","first-page":"12","DOI":"10.1016\/j.bbadis.2014.11.009","article-title":"Threonine 56 phosphorylation of Bcl-2 is required for LRRK2 G2019S-induced mitochondrial depolarization and autophagy","volume":"1852","author":"Su","year":"2015","journal-title":"Biochim Biophys Acta"},{"key":"R52-20260305","doi-asserted-by":"crossref","first-page":"1931","DOI":"10.1093\/hmg\/dds003","article-title":"LRRK2 regulates mitochondrial dynamics and function through direct interaction with DLP1","volume":"21","author":"Wang","year":"2012","journal-title":"Hum Mol Genet"},{"key":"R53-20260305","doi-asserted-by":"crossref","first-page":"172","DOI":"10.1016\/j.nbd.2015.02.031","article-title":"Progressive dopaminergic alterations and mitochondrial abnormalities in LRRK2 G2019S knock-in mice","volume":"78","author":"Yue","year":"2015","journal-title":"Neurobiol Dis"},{"key":"R54-20260305","doi-asserted-by":"crossref","first-page":"878","DOI":"10.1016\/j.stemcr.2019.03.004","article-title":"Neural stem cells of Parkinson\u2019s disease patients exhibit aberrant mitochondrial morphology and functionality","volume":"12","author":"Walter","year":"2019","journal-title":"Stem Cell Reports"},{"key":"R55-20260305","doi-asserted-by":"crossref","first-page":"960","DOI":"10.1089\/scd.2017.0286","article-title":"In vitro modeling of leucine-rich repeat kinase 2 G2019S-mediated Parkinson\u2019s disease pathology","volume":"27","author":"Vermilyea","year":"2018","journal-title":"Stem Cells Dev"},{"key":"R56-20260305","doi-asserted-by":"crossref","DOI":"10.1093\/jmcb\/mjab079","article-title":"LRRK2 regulates actin assembly for spindle migration and mitochondrial function in mouse oocyte meiosis","volume":"14","author":"Pan","year":"2022","journal-title":"J Mol Cell Biol"},{"key":"R57-20260305","doi-asserted-by":"crossref","first-page":"11151","DOI":"10.1523\/JNEUROSCI.3791-16.2017","article-title":"Mitochondrial calcium dysregulation contributes to dendrite degeneration mediated by PD\/LBD-associated LRRK2 mutants","volume":"37","author":"Verma","year":"2017","journal-title":"J Neurosci"},{"key":"R58-20260305","doi-asserted-by":"crossref","first-page":"265","DOI":"10.1038\/s41419-019-1469-5","article-title":"LRRK2 deficiency induced mitochondrial Ca(2+) efflux inhibition can be rescued by Na(+)\/Ca(2+)\/Li(+) exchanger upregulation","volume":"10","author":"Ludtmann","year":"2019","journal-title":"Cell Death Dis"},{"key":"R59-20260305","doi-asserted-by":"crossref","first-page":"E8844","DOI":"10.1073\/pnas.1721136115","article-title":"Altered ER-mitochondria contact impacts mitochondria calcium homeostasis and contributes to neurodegeneration in vivo in disease models","volume":"115","author":"Lee","year":"2018","journal-title":"Proc Natl Acad Sci U S A"},{"key":"R60-20260305","doi-asserted-by":"crossref","DOI":"10.1016\/j.nbd.2022.105885","article-title":"Cell-free mitochondrial DNA deletions in idiopathic, but not LRRK2, Parkinson\u2019s disease","volume":"174","author":"Puigr\u00f2s","year":"2022","journal-title":"Neurobiol Dis"},{"key":"R61-20260305","doi-asserted-by":"crossref","first-page":"485","DOI":"10.1186\/s12964-024-01844-y","article-title":"Loss of mitochondrial Ca(2+) response and CaMKII\/ERK activation by LRRK2(R1441G) mutation correlate with impaired depolarization-induced mitophagy","volume":"22","author":"Chang","year":"2024","journal-title":"Cell Commun Signal"},{"key":"R62-20260305","doi-asserted-by":"crossref","first-page":"9220","DOI":"10.3390\/ijms25179220","article-title":"The GBA1 K198E variant is associated with suppression of glucocerebrosidase activity, autophagy impairment, oxidative stress, mitochondrial damage, and apoptosis in skin fibroblasts","volume":"25","author":"Perez-Abshana","year":"2024","journal-title":"Int J Mol Sci"},{"key":"R63-20260305","doi-asserted-by":"crossref","first-page":"1319","DOI":"10.1093\/hmg\/ddm080","article-title":"Apoptotic mechanisms in mutant LRRK2-mediated cell death","volume":"16","author":"Iaccarino","year":"2007","journal-title":"Hum Mol Genet"},{"key":"R64-20260305","doi-asserted-by":"crossref","first-page":"3487","DOI":"10.3390\/ijms22073487","article-title":"PGC-1s in the spotlight with Parkinson\u2019s disease","volume":"22","author":"Piccinin","year":"2021","journal-title":"Int J Mol Sci"},{"key":"R65-20260305","doi-asserted-by":"crossref","first-page":"709","DOI":"10.1016\/j.stem.2016.08.002","article-title":"Functional impairment in miro degradation and mitophagy is a shared feature in familial and sporadic Parkinson\u2019s disease","volume":"19","author":"Hsieh","year":"2016","journal-title":"Cell Stem Cell"},{"key":"R66-20260305","doi-asserted-by":"crossref","DOI":"10.1074\/mcp.M110.001172","article-title":"A quick screen for Lrrk2 interaction partners \u2013 leucine-rich repeat kinase 2 is involved in actin cytoskeleton dynamics","volume":"10","author":"Meixner","year":"2011","journal-title":"Molecular & Cellular Proteomics"},{"key":"R67-20260305","doi-asserted-by":"crossref","first-page":"1013","DOI":"10.1002\/jcp.30588","article-title":"LRRK2 and WAVE2 regulate microglial-transition through distinct morphological phenotypes to induce neurotoxicity in a novel two-hit in vitro model of neurodegeneration","volume":"237","author":"Fenner","year":"2022","journal-title":"J Cell Physiol"},{"key":"R68-20260305","doi-asserted-by":"crossref","first-page":"116","DOI":"10.1016\/j.nbd.2008.06.016","article-title":"Wild-type LRRK2 but not its mutant attenuates stress-induced cell death via ERK pathway","volume":"32","author":"Liou","year":"2008","journal-title":"Neurobiology of Disease"},{"key":"R69-20260305","doi-asserted-by":"crossref","first-page":"5577","DOI":"10.4049\/jimmunol.1000548","article-title":"LRRK2 is involved in the IFN-\u03b3 response and host response to pathogens","volume":"185","author":"Gardet","year":"2010","journal-title":"The Journal of Immunology"},{"key":"R70-20260305","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1155\/2021\/9969842","article-title":"LRRK2 kinase inhibitor rejuvenates oxidative stress-induced cellular senescence in neuronal cells","volume":"2021","author":"Ho","year":"2021","journal-title":"Oxidative Medicine and Cellular Longevity"},{"key":"R71-20260305","first-page":"21","article-title":"Downregulated LRRK2 gene expression inhibits proliferation and migration while promoting the apoptosis of thyroid cancer cells by inhibiting activation of the JNK signaling pathway","volume":"55","author":"Jiang","year":"2019","journal-title":"International Journal of Oncology"},{"key":"R72-20260305","doi-asserted-by":"crossref","first-page":"1125","DOI":"10.1038\/s41419-018-1180-y","article-title":"Brain injury induces HIF-1\u03b1-dependent transcriptional activation of LRRK2 that exacerbates brain damage","volume":"9","author":"Bae","year":"2018","journal-title":"Cell Death & Disease"},{"key":"R73-20260305","doi-asserted-by":"crossref","first-page":"2550","DOI":"10.3390\/cells12212550","article-title":"LRRK2 attenuates antioxidant response in familial Parkinson\u2019s disease derived neural stem cells","volume":"12","author":"Kim","year":"2023","journal-title":"Cells"},{"key":"R74-20260305","doi-asserted-by":"crossref","first-page":"791","DOI":"10.1038\/nrn2935","article-title":"The role of leucine-rich repeat kinase 2 (LRRK2) in Parkinson\u2019s disease","volume":"11","author":"Cookson","year":"2010","journal-title":"Nature Reviews Neuroscience"},{"key":"R75-20260305","doi-asserted-by":"crossref","first-page":"608","DOI":"10.1093\/hmg\/dds470","article-title":"MicroRNA-205 regulates the expression of Parkinson\u2019s disease-related leucine-rich repeat kinase 2 protein","volume":"22","author":"Cho","year":"2013","journal-title":"Human Molecular Genetics"},{"key":"R76-20260305","doi-asserted-by":"crossref","first-page":"405","DOI":"10.1042\/BJ20100784","article-title":"Inhibition of LRRK2 kinase activity leads to dephosphorylation of Ser910\/Ser935, disruption of 14-3-3 binding and altered cytoplasmic localization","volume":"430","author":"Dzamko","year":"2010","journal-title":"Biochemical Journal"},{"key":"R77-20260305","doi-asserted-by":"crossref","first-page":"1623","DOI":"10.1038\/cdd.2012.42","article-title":"(G2019S) LRRK2 activates MKK4-JNK pathway and causes degeneration of SN dopaminergic neurons in a transgenic mouse model of PD","volume":"19","author":"Chen","year":"2012","journal-title":"Cell Death & Differentiation"},{"key":"R78-20260305","doi-asserted-by":"crossref","first-page":"19602","DOI":"10.1002\/jcp.28560","article-title":"Sodium butyrate suppresses NOD1-mediated inflammatory molecules expressed in bovine hepatocytes during iE-DAP and LPS treatment","volume":"234","author":"Roy","year":"2019","journal-title":"J Cell Physiol"},{"key":"R79-20260305","doi-asserted-by":"crossref","DOI":"10.1016\/j.bbrep.2025.101941","article-title":"Resiquimod induces a mixed Th1 and Th2 response via STAT1 and STAT3 signalling in chickens","volume":"41","author":"Kappala","year":"2025","journal-title":"Biochemistry and Biophysics Reports"},{"key":"R80-20260305","doi-asserted-by":"crossref","first-page":"991","DOI":"10.1136\/gutjnl-2020-323126","article-title":"RNA helicase DDX5 enables STAT1 mRNA translation and interferon signalling in hepatitis B virus replicating hepatocytes","volume":"71","author":"Sun","year":"2022","journal-title":"Gut"},{"key":"R81-20260305","doi-asserted-by":"crossref","first-page":"931","DOI":"10.1002\/ijc.31357","article-title":"IFN-\u03b3-mediated inhibition of lung cancer correlates with PD-L1 expression and is regulated by PI3K-AKT signaling","volume":"143","author":"Gao","year":"2018","journal-title":"Int J Cancer"},{"key":"R82-20260305","doi-asserted-by":"crossref","first-page":"994","DOI":"10.1212\/WNL.0000000000002436","article-title":"Urinary LRRK2 phosphorylation predicts parkinsonian phenotypes in G2019S LRRK2 carriers","volume":"86","author":"Fraser","year":"2016","journal-title":"Neurology"},{"key":"R83-20260305","doi-asserted-by":"crossref","first-page":"4988","DOI":"10.1093\/hmg\/ddt346","article-title":"LRRK2 secretion in exosomes is regulated by 14-3-3","volume":"22","author":"Fraser","year":"2013","journal-title":"Human Molecular Genetics"},{"key":"R84-20260305","doi-asserted-by":"crossref","first-page":"585","DOI":"10.1038\/s41586-022-04884-x","article-title":"The gut metabolite indole-3 propionate promotes nerve regeneration and repair","volume":"607","author":"Serger","year":"2022","journal-title":"Nature"},{"key":"R85-20260305","doi-asserted-by":"crossref","first-page":"7","DOI":"10.1186\/s13024-021-00509-5","article-title":"Pathological \u03b1-synuclein recruits LRRK2 expressing pro-inflammatory monocytes to the brain","volume":"17","author":"Xu","year":"2022","journal-title":"Mol Neurodegener"},{"key":"R86-20260305","doi-asserted-by":"crossref","first-page":"5163","DOI":"10.1038\/s41467-020-18755-4","article-title":"Interferon-\u03b3 signaling synergizes with LRRK2 in neurons and microglia derived from human induced pluripotent stem cells","volume":"11","author":"Panagiotakopoulou","year":"2020","journal-title":"Nature Communications"},{"key":"R87-20260305","doi-asserted-by":"crossref","first-page":"272","DOI":"10.1111\/j.1365-2990.2007.00888.x","article-title":"LRRK2 is a component of granular alpha-synuclein pathology in the brainstem of Parkinson\u2019s disease","volume":"34","author":"Alegre-Abarrategui","year":"2007","journal-title":"Neuropathology and Applied Neurobiology"},{"key":"R88-20260305","doi-asserted-by":"crossref","first-page":"949","DOI":"10.1126\/science.1227157","article-title":"Pathological \u03b1-synuclein transmission initiates parkinson-like neurodegeneration in nontransgenic mice","volume":"338","author":"Luk","year":"2012","journal-title":"Science"},{"key":"R89-20260305","doi-asserted-by":"crossref","first-page":"712","DOI":"10.1016\/j.cell.2021.12.041","article-title":"Tau interactome maps synaptic and mitochondrial processes associated with neurodegeneration","volume":"185","author":"Tracy","year":"2022","journal-title":"Cell"},{"key":"R90-20260305","doi-asserted-by":"crossref","first-page":"1305","DOI":"10.3233\/JAD-170788","article-title":"Nature of tau-associated neurodegeneration and the molecular mechanisms","volume":"62","author":"Yang","year":"2018","journal-title":"Journal of Alzheimers Disease"},{"key":"R91-20260305","doi-asserted-by":"crossref","first-page":"2140","DOI":"10.1016\/j.cub.2021.02.061","article-title":"Increased LRRK2 kinase activity alters neuronal autophagy by disrupting the axonal transport of autophagosomes","volume":"31","author":"Boecker","year":"2021","journal-title":"Current Biology"},{"key":"R92-20260305","doi-asserted-by":"crossref","first-page":"118","DOI":"10.1038\/s41531-022-00380-1","article-title":"Parkinson-causing mutations in LRRK2 impair the physiological tetramerization of endogenous \u03b1-synuclein in human neurons","volume":"8","author":"Fonseca-Ornelas","year":"2022","journal-title":"npj Parkinson\u2019s Disease"},{"key":"R93-20260305","doi-asserted-by":"crossref","first-page":"634","DOI":"10.1016\/j.bbadis.2008.09.001","article-title":"Intrabody and Parkinson\u2019s disease","volume":"1792","author":"Zhou","year":"2009","journal-title":"Biochim Biophys Acta"},{"key":"R94-20260305","doi-asserted-by":"crossref","first-page":"6760","DOI":"10.3390\/ijms22136760","article-title":"The C-terminal domain of LRRK2 with the G2019S substitution increases mutant A53T \u03b1-synuclein toxicity in dopaminergic neurons in vivo","volume":"22","author":"Cresto","year":"2021","journal-title":"International Journal of Molecular Sciences"},{"key":"R95-20260305","doi-asserted-by":"crossref","first-page":"5089","DOI":"10.1016\/j.cell.2021.09.007","article-title":"Microglia jointly degrade fibrillar alpha-synuclein cargo by distribution through tunneling nanotubes","volume":"184","author":"Scheiblich","year":"2021","journal-title":"Cell"},{"key":"R96-20260305","doi-asserted-by":"crossref","first-page":"3658","DOI":"10.1016\/j.yexcr.2007.07.007","article-title":"The Parkinson\u2019s disease-associated protein, leucine-rich repeat kinase 2 (LRRK2), is an authentic GTPase thatstimulates kinase activity","volume":"313","author":"Guo","year":"2007","journal-title":"Experimental Cell Research"},{"key":"R97-20260305","doi-asserted-by":"crossref","first-page":"3955","DOI":"10.1093\/hmg\/ddp337","article-title":"Mutations in the LRRK2 Roc-COR tandem domain link Parkinson\u2019s disease to Wnt signalling pathways","volume":"18","author":"Sancho","year":"2009","journal-title":"Human Molecular Genetics"},{"key":"R98-20260305","article-title":"A missense LRRK2 variant is a risk factor for excessive inflammatory responses in leprosy","volume":"10","author":"Johnson","year":"2016","journal-title":"PLOS Neglected Tropical Diseases"},{"key":"R99-20260305","doi-asserted-by":"crossref","first-page":"112","DOI":"10.1038\/gene.2014.72","article-title":"Association of the LRRK2 genetic polymorphisms with leprosy in Han Chinese from Southwest China","volume":"16","author":"Wang","year":"2015","journal-title":"Genes Immun"},{"key":"R100-20260305","doi-asserted-by":"crossref","DOI":"10.1371\/journal.ppat.1011260","article-title":"Allele-dependent interaction of LRRK2 and NOD2 in leprosy","volume":"19","author":"Dallmann-Sauer","year":"2023","journal-title":"PLoS Pathog"},{"key":"R101-20260305","doi-asserted-by":"crossref","first-page":"10124","DOI":"10.1073\/pnas.2002654117","article-title":"Reply to Zhang et al.: The differential role of LRRK2 variants in nested leprosy phenotypes","volume":"117","author":"Fava","year":"2020","journal-title":"Proc Natl Acad Sci U S A"},{"key":"R102-20260305","doi-asserted-by":"crossref","first-page":"10122","DOI":"10.1073\/pnas.2000533117","article-title":"Is there an antagonistic pleiotropic effect of a LRRK2 mutation on leprosy and Parkinson\u2019s disease?","volume":"117","author":"Zhang","year":"2020","journal-title":"Proc Natl Acad Sci U S A"},{"key":"R103-20260305","doi-asserted-by":"crossref","DOI":"10.1073\/pnas.2106685118","article-title":"LRRK2 plays essential roles in maintaining lung homeostasis and preventing the development of pulmonary fibrosis","volume":"118","author":"Tian","year":"2021","journal-title":"Proceedings of the National Academy of Sciences"},{"key":"R104-20260305","doi-asserted-by":"crossref","first-page":"3","DOI":"10.1186\/s12918-017-0524-z","article-title":"Meta-analysis of human gene expression in response to Mycobacterium tuberculosis infection reveals potential therapeutic targets","volume":"12","author":"Wang","year":"2018","journal-title":"BMC Syst Biol"},{"key":"R105-20260305","doi-asserted-by":"crossref","DOI":"10.7554\/eLife.51071","article-title":"LRRK2 maintains mitochondrial homeostasis and regulates innate immune responses to Mycobacterium tuberculosis","volume":"9","author":"Weindel","year":"2020","journal-title":"eLife"},{"key":"R106-20260305","doi-asserted-by":"crossref","DOI":"10.1002\/ctm2.341","article-title":"LRRK2 inhibition potentiates PARP inhibitor cytotoxicity through inhibiting homologous recombination-mediated DNA double strand break repair","volume":"11","author":"Chen","year":"2021","journal-title":"Clinical and Translational Medicine"},{"key":"R107-20260305","doi-asserted-by":"crossref","first-page":"1750","DOI":"10.1093\/hmg\/ddab138","article-title":"NovelLRRK2mutations and other rare, non-BAP1-related candidate tumor predisposition gene variants in high-risk cancer families with mesothelioma and other tumors","volume":"30","author":"Cheung","year":"2021","journal-title":"Human Molecular Genetics"},{"key":"R108-20260305","doi-asserted-by":"crossref","first-page":"2097","DOI":"10.1038\/s41598-021-81639-0","article-title":"Loss of Parkinson\u2019s susceptibility gene LRRK2 promotes carcinogen-induced lung tumorigenesis","volume":"11","author":"Lebovitz","year":"2021","journal-title":"Scientific Reports"},{"key":"R109-20260305","doi-asserted-by":"crossref","first-page":"204","DOI":"10.1080\/15548627.2021.1954779","article-title":"LRRK2 is required for CD38-mediated NAADP-Ca signaling and the downstream activation of TFEB (transcription factor EB) in immune cells","volume":"18","author":"Nabar","year":"2022","journal-title":"Autophagy"},{"key":"R110-20260305","article-title":"LRRK2 regulates endoplasmic reticulum\u2013mitochondrial tethering through the PERK-mediated ubiquitination pathway","volume":"39","author":"Toyofuku","year":"2019","journal-title":"The EMBO Journal"},{"key":"R111-20260305","doi-asserted-by":"crossref","first-page":"302","DOI":"10.3390\/cancers14020302","article-title":"Biomarkers associated with immune-related adverse events under checkpoint inhibitors in metastatic melanoma","volume":"14","author":"W\u00f6lffer","year":"2022","journal-title":"Cancers (Basel)"},{"key":"R112-20260305","doi-asserted-by":"crossref","DOI":"10.3389\/fimmu.2023.1293729","article-title":"Leveraging diverse cell-death related signature predicts the prognosis and immunotherapy response in renal clear cell carcinoma","volume":"14","author":"Wu","year":"2023","journal-title":"Front Immunol"},{"key":"R113-20260305","doi-asserted-by":"crossref","first-page":"343","DOI":"10.1186\/s12935-021-02047-y","article-title":"LRRK2 is a candidate prognostic biomarker for clear cell renal cell carcinoma","volume":"21","author":"Yang","year":"2021","journal-title":"Cancer Cell Int"},{"key":"R114-20260305","article-title":"Significant and durable clinical response to sorafenib and radiation therapy for a patient with stage IV hepatocellular carcinoma and LRRK2 mutation","volume":"3","author":"Yang","year":"2019","journal-title":"JCO Precis Oncol"},{"key":"R115-20260305","doi-asserted-by":"crossref","first-page":"86","DOI":"10.1080\/15548627.2021.1909406","article-title":"How autophagy controls the intestinal epithelial barrier","volume":"18","author":"Foerster","year":"2022","journal-title":"Autophagy"},{"key":"R116-20260305","article-title":"Targeting specific kinase substrates rescues increased colitis severity induced by the Crohn\u2019s disease-linked LRRK2-N2081D variant","author":"Heaton","year":"2024","journal-title":"bioRxiv"},{"key":"R117-20260305","doi-asserted-by":"crossref","first-page":"26","DOI":"10.1038\/s41531-021-00170-1","article-title":"Is LRRK2 the missing link between inflammatory bowel disease and Parkinson\u2019s disease?","volume":"7","author":"Herrick","year":"2021","journal-title":"NPJ Parkinsons Dis"},{"key":"R118-20260305","doi-asserted-by":"crossref","DOI":"10.1126\/sciimmunol.adi7907","article-title":"Macrophage LRRK2 hyperactivity impairs autophagy and induces Paneth cell dysfunction","volume":"9","author":"Sun","year":"2024","journal-title":"Sci Immunol"},{"key":"R119-20260305","article-title":"Allele-dependent interaction of LRRK2 and NOD2 in leprosy","volume":"19","author":"Hawn","year":"2023","journal-title":"PLOS Pathogens"},{"key":"R120-20260305","doi-asserted-by":"crossref","first-page":"898","DOI":"10.1038\/ni.3255","article-title":"LRRK2 and Nod2 promote lysozyme sorting in Paneth cells","volume":"16","author":"Rocha","year":"2015","journal-title":"Nature Immunology"},{"key":"R121-20260305","doi-asserted-by":"crossref","first-page":"15616","DOI":"10.1073\/pnas.1901805116","article-title":"Pleiotropic effects for Parkin and LRRK2 in leprosy type-1 reactions and Parkinson\u2019s disease","volume":"116","author":"Fava","year":"2019","journal-title":"Proc Natl Acad Sci U S A"},{"key":"R122-20260305","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pntd.0004412","article-title":"A Missense LRRK2 variant is a risk factor for excessive inflammatory responses in leprosy","volume":"10","author":"Fava","year":"2016","journal-title":"PLoS Negl Trop Dis"},{"key":"R123-20260305","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pone.0073103","article-title":"LRRK2 and RIPK2 variants in the NOD 2-mediated signaling pathway are associated with susceptibility to Mycobacterium leprae in Indian populations","volume":"8","author":"Marcinek","year":"2013","journal-title":"PLoS One"},{"key":"R124-20260305","doi-asserted-by":"crossref","first-page":"3109","DOI":"10.3390\/biomedicines11123109","article-title":"Study on potential differentially expressed genes in idiopathic pulmonary fibrosis by bioinformatics and next-generation sequencing data analysis","volume":"11","author":"Giriyappagoudar","year":"2023","journal-title":"Biomedicines"},{"key":"R125-20260305","doi-asserted-by":"crossref","DOI":"10.1126\/scitranslmed.abo1557","article-title":"A blood-based marker of mitochondrial DNA damage in Parkinson\u2019s disease","volume":"15","author":"Qi","year":"2023","journal-title":"Sci Transl Med"},{"key":"R126-20260305","doi-asserted-by":"crossref","first-page":"159","DOI":"10.1515\/revneuro-2020-0083","article-title":"Genetic parkinsonisms and cancer: a systematic review and meta-analysis","volume":"32","author":"Sturchio","year":"2021","journal-title":"Rev Neurosci"},{"key":"R127-20260305","doi-asserted-by":"crossref","first-page":"565","DOI":"10.3390\/cells13070565","article-title":"LRRK2 G2019S promotes colon cancer potentially via LRRK2-GSDMD axis-mediated gut inflammation","volume":"13","author":"Wang","year":"2024","journal-title":"Cells"},{"key":"R128-20260305","doi-asserted-by":"crossref","first-page":"869","DOI":"10.1038\/s41591-020-0893-5","article-title":"The effect of LRRK2 loss-of-function variants in humans","volume":"26","author":"Whiffin","year":"2020","journal-title":"Nat Med"},{"key":"R129-20260305","doi-asserted-by":"crossref","DOI":"10.7554\/eLife.67604","article-title":"Pharmacological rescue of impaired mitophagy in Parkinson\u2019s disease-related LRRK2 G2019S knock-in mice","volume":"10","author":"Singh","year":"2021","journal-title":"eLife"},{"key":"R130-20260305","doi-asserted-by":"crossref","first-page":"921","DOI":"10.1021\/jm401654j","article-title":"Discovery of highly potent, selective, and brain-penetrant aminopyrazole leucine-rich repeat kinase 2 (LRRK2) Small molecule inhibitors","volume":"57","author":"Estrada","year":"2014","journal-title":"Journal of Medicinal Chemistry"},{"key":"R131-20260305","doi-asserted-by":"crossref","first-page":"386","DOI":"10.1002\/mds.29297","article-title":"LRRK2 inhibition by BIIB122 in healthy participants and patients with Parkinson\u2019s disease","volume":"38","author":"Jennings","year":"2023","journal-title":"Mov Disord"},{"key":"R132-20260305","doi-asserted-by":"crossref","first-page":"3015","DOI":"10.1016\/j.apsb.2021.02.016","article-title":"Targeting autophagy using small-molecule compounds to improve potential therapy of Parkinson\u2019s disease","volume":"11","author":"Zhang","year":"2021","journal-title":"Acta Pharm Sin B"},{"key":"R133-20260305","doi-asserted-by":"crossref","first-page":"e1368","DOI":"10.1038\/cddis.2014.320","article-title":"The LRRK2 inhibitor GSK2578215A induces protective autophagy in SH-SY5Y cells: involvement of Drp-1-mediated mitochondrial fission and mitochondrial-derived ROS signaling","volume":"5","author":"Saez-Atienzar","year":"2014","journal-title":"Cell Death & Disease"},{"key":"R134-20260305","doi-asserted-by":"crossref","first-page":"658","DOI":"10.1021\/ml300123a","article-title":"Brain penetrant LRRK2 Inhibitor","volume":"3","author":"Choi","year":"2012","journal-title":"ACS Medicinal Chemistry Letters"},{"key":"R135-20260305","doi-asserted-by":"crossref","first-page":"203","DOI":"10.1038\/nchembio.538","article-title":"Characterization of a selective inhibitor of the Parkinson\u2019s disease kinase LRRK2","volume":"7","author":"Deng","year":"2011","journal-title":"Nature Chemical Biology"},{"key":"R136-20260305","doi-asserted-by":"crossref","first-page":"419","DOI":"10.1021\/jm5014055","article-title":"Discovery and preclinical profiling of 3-[4-(Morpholin-4-yl)-7H-pyrrolo[2,3-d]pyrimidin-5-yl]benzonitrile (PF-06447475), a highly potent, selective, brain penetrant, and in vivo active LRRK2 kinase inhibitor","volume":"58","author":"Henderson","year":"2014","journal-title":"Journal of Medicinal Chemistry"},{"key":"R137-20260305","doi-asserted-by":"crossref","first-page":"344","DOI":"10.1038\/s41586-020-2673-2","article-title":"Structure of LRRK2 in Parkinson\u2019s disease and model for microtubule interaction","volume":"588","author":"Deniston","year":"2020","journal-title":"Nature"},{"key":"R138-20260305","doi-asserted-by":"crossref","DOI":"10.1073\/pnas.2100844118","article-title":"Conformation and dynamics of the kinase domain drive subcellular location and activation of LRRK2","volume":"118","author":"Schmidt","year":"2021","journal-title":"Proceedings of the National Academy of Sciences"},{"key":"R139-20260305","doi-asserted-by":"crossref","DOI":"10.3390\/cells11050861","article-title":"LRRK2 inhibition mitigates the neuroinflammation caused by TLR2-specific \u03b1-synuclein and alleviates neuroinflammation-derived dopaminergic neuronal loss","volume":"11","author":"Ho","year":"2022","journal-title":"Cells"},{"key":"R140-20260305","doi-asserted-by":"crossref","first-page":"361","DOI":"10.1002\/mds.29343","article-title":"LRRK2-Targeting Therapies March Through the Valley of Death","volume":"38","author":"West","year":"2023","journal-title":"Mov Disord"},{"key":"R141-20260305","doi-asserted-by":"crossref","first-page":"480","DOI":"10.3390\/cells10020480","article-title":"A LRRK2 GTP binding inhibitor, 68, reduces LPS-induced signaling events and TNF-\u03b1 release in human lymphoblasts","volume":"10","author":"Li","year":"2021","journal-title":"Cells"},{"key":"R142-20260305","article-title":"A novel GTP-binding inhibitor, FX2149, attenuates LRRK2 toxicity in Parkinson\u2019s disease models","volume":"10","author":"Andrabi","year":"2015","journal-title":"Plos One"},{"key":"R143-20260305","doi-asserted-by":"crossref","DOI":"10.1016\/j.neuint.2021.105070","article-title":"Abrogation of LRRK2 dependent Rab10 phosphorylation with TLR4 activation and alterations in evoked cytokine release in immune cells","volume":"147","author":"Nazish","year":"2021","journal-title":"Neurochemistry International"},{"key":"R144-20260305","doi-asserted-by":"crossref","first-page":"e21","DOI":"10.1042\/BJ20150785","article-title":"LRRK2 and ubiquitination: implications for kinase inhibitor therapy","volume":"470","author":"Melrose Heather","year":"2015","journal-title":"Biochemical Journal"},{"key":"R145-20260305","doi-asserted-by":"crossref","first-page":"4201","DOI":"10.1093\/hmg\/dds244","article-title":"G2019S leucine-rich repeat kinase 2 causes uncoupling protein-mediated mitochondrial depolarization","volume":"21","author":"Papkovskaia","year":"2012","journal-title":"Hum Mol Genet"},{"key":"R146-20260305","doi-asserted-by":"crossref","first-page":"10","DOI":"10.1016\/j.mito.2023.09.002","article-title":"The Parkinson\u2019s disease-associated mutation LRRK2 G2385R alters mitochondrial biogenesis via the PGC-1\u03b1-TFAM pathway","volume":"73","author":"Xue","year":"2023","journal-title":"Mitochondrion"},{"key":"R147-20260305","doi-asserted-by":"crossref","first-page":"846","DOI":"10.1212\/WNL.0000000000001905","article-title":"UDCA exerts beneficial effect on mitochondrial dysfunction in LRRK2(G2019S) carriers and in vivo","volume":"85","author":"Mortiboys","year":"2015","journal-title":"Neurology"},{"key":"R148-20260305","doi-asserted-by":"crossref","first-page":"159","DOI":"10.1016\/j.neulet.2014.09.042","article-title":"A novel mitochondrially-targeted apocynin derivative prevents hyposmia and loss of motor function in the leucine-rich repeat kinase 2 (LRRK2(R1441G)) transgenic mouse model of Parkinson\u2019s disease","volume":"583","author":"Dranka","year":"2014","journal-title":"Neurosci Lett"},{"key":"R149-20260305","doi-asserted-by":"crossref","first-page":"57","DOI":"10.1016\/j.neulet.2013.05.034","article-title":"Diapocynin prevents early Parkinson\u2019s disease symptoms in the leucine-rich repeat kinase 2 (LRRK2R1441G) transgenic mouse","volume":"549","author":"Dranka","year":"2013","journal-title":"Neurosci Lett"},{"key":"R150-20260305","doi-asserted-by":"crossref","first-page":"16930","DOI":"10.1021\/jacs.2c05499","article-title":"Discovery of XL01126: A potent, fast, cooperative, selective, orally bioavailable, and blood\u2013brain barrier penetrant PROTAC degrader of leucine-rich repeat kinase 2","volume":"144","author":"Liu","year":"2022","journal-title":"Journal of the American Chemical Society"},{"key":"R151-20260305","doi-asserted-by":"crossref","first-page":"508","DOI":"10.1016\/j.omtn.2017.08.002","article-title":"LRRK2 antisense oligonucleotides ameliorate \u03b1-synuclein inclusion formation in a Parkinson\u2019s disease mouse model","volume":"8","author":"Zhao","year":"2017","journal-title":"Molecular Therapy - Nucleic Acids"},{"key":"R152-20260305","doi-asserted-by":"crossref","first-page":"1814","DOI":"10.3390\/biom12121814","article-title":"Advances in gene therapy techniques to treat LRRK2 gene mutation","volume":"12","author":"Chung","year":"2022","journal-title":"Biomolecules"},{"key":"R153-20260305","article-title":"Transcriptome signatures of human neural stem cells derived from LRRK2 gene therapeutic cells","volume":"15","author":"Kim","year":"2025","journal-title":"Sci Rep"},{"key":"R154-20260305","doi-asserted-by":"crossref","first-page":"47","DOI":"10.1186\/s13024-024-00738-4","article-title":"Single molecule array measures of LRRK2 kinase activity in serum link Parkinson\u2019s disease severity to peripheral inflammation","volume":"19","author":"Yuan","year":"2024","journal-title":"Mol Neurodegener"},{"key":"R155-20260305","doi-asserted-by":"crossref","first-page":"1208","DOI":"10.4161\/auto.5.8.9894","article-title":"Parkinson disease, LRRK2 and the endocytic-autophagic pathway","volume":"5","author":"Alegre-Abarrategui","year":"2009","journal-title":"Autophagy"},{"key":"R156-20260305","doi-asserted-by":"crossref","first-page":"129","DOI":"10.1111\/j.1601-183X.2007.00342.x","article-title":"Genetic findings in Parkinson\u2019s disease and translation into treatment: A leading role for mitochondria?","volume":"7","author":"Bogaerts","year":"2008","journal-title":"Genes Brain Behav"},{"key":"R157-20260305","doi-asserted-by":"crossref","first-page":"158","DOI":"10.1111\/jnc.15588","article-title":"LRRK2-G2019S mice display alterations in glutamatergic synaptic transmission in midbrain dopamine neurons","volume":"161","author":"Skiteva","year":"2022","journal-title":"J Neurochem"},{"key":"R158-20260305","doi-asserted-by":"crossref","first-page":"5577","DOI":"10.4049\/jimmunol.1000548","article-title":"LRRK2 is involved in the IFN-gamma response and host response to pathogens","volume":"185","author":"Gardet","year":"2010","journal-title":"J Immunol"},{"key":"R159-20260305","doi-asserted-by":"crossref","first-page":"2097","DOI":"10.1038\/s41598-021-81639-0","article-title":"Loss of Parkinson\u2019s susceptibility gene LRRK2 promotes carcinogen-induced lung tumorigenesis","volume":"11","author":"Lebovitz","year":"2021","journal-title":"Sci Rep"},{"key":"R160-20260305","doi-asserted-by":"crossref","first-page":"1439","DOI":"10.1073\/pnas.1012500108","article-title":"Chromosomal amplification of leucine-rich repeat kinase-2 (LRRK2) is required for oncogenic MET signaling in papillary renal and thyroid carcinomas","volume":"108","author":"Looyenga","year":"2011","journal-title":"Proc Natl Acad Sci U S A"},{"key":"R161-20260305","first-page":"225","article-title":"Association between LRRK2 and 4E-BP1 protein levels in normal and malignant cells","volume":"27","author":"Pons","year":"2012","journal-title":"Oncol Rep"},{"key":"R162-20260305","doi-asserted-by":"crossref","first-page":"1750","DOI":"10.1093\/hmg\/ddab138","article-title":"Novel LRRK2 mutations and other rare, non-BAP1-related candidate tumor predisposition gene variants in high-risk cancer families with mesothelioma and other tumors","volume":"30","author":"Cheung","year":"2021","journal-title":"Hum Mol Genet"},{"key":"R163-20260305","first-page":"799","article-title":"LINC00707 promotes multidrug resistance of ovarian cancer cells by targeting the miR-382-5p\/LRRK2 axis","volume":"70","author":"Zhao","year":"2023","journal-title":"Acta Biochim Pol"},{"key":"R164-20260305","doi-asserted-by":"crossref","first-page":"787","DOI":"10.1080\/13543784.2023.2263357","article-title":"DNL151, DNL201, and BIIB094: experimental agents for the treatment of Parkinson\u2019s disease","volume":"32","author":"M\u00fcller","year":"2023","journal-title":"Expert Opin Investig Drugs"},{"key":"R165-20260305","doi-asserted-by":"crossref","first-page":"162","DOI":"10.1111\/cns.12660","article-title":"Effects of LRRK2 inhibitors on nigrostriatal dopaminergic neurotransmission","volume":"23","author":"Qin","year":"2017","journal-title":"CNS Neurosci Ther"},{"key":"R166-20260305","doi-asserted-by":"crossref","first-page":"561","DOI":"10.1111\/jnc.12483","article-title":"Phosphoproteomic evaluation of pharmacological inhibition of leucine-rich repeat kinase 2 reveals significant off-target effects of LRRK-2-IN-1","volume":"128","author":"Luerman","year":"2014","journal-title":"J Neurochem"},{"key":"R167-20260305","doi-asserted-by":"crossref","first-page":"5625","DOI":"10.1016\/j.bmcl.2012.06.104","article-title":"GSK2578215A; a potent and highly selective 2-arylmethyloxy-5-substitutent-N-arylbenzamide LRRK2 kinase inhibitor","volume":"22","author":"Reith","year":"2012","journal-title":"Bioorg Med Chem Lett"},{"key":"R168-20260305","doi-asserted-by":"crossref","first-page":"397","DOI":"10.1124\/jpet.115.227587","article-title":"MLi-2, a potent, selective, and centrally active compound for exploring the therapeutic potential and safety of LRRK2 kinase inhibition","volume":"355","author":"Fell","year":"2015","journal-title":"J Pharmacol Exp Ther"},{"key":"R169-20260305","doi-asserted-by":"crossref","first-page":"921","DOI":"10.1021\/jm401654j","article-title":"Discovery of highly potent, selective, and brain-penetrant aminopyrazole leucine-rich repeat kinase 2 (LRRK2) small molecule inhibitors","volume":"57","author":"Estrada","year":"2014","journal-title":"J Med Chem"},{"key":"R170-20260305","doi-asserted-by":"crossref","DOI":"10.1126\/scitranslmed.abj2658","article-title":"Preclinical and clinical evaluation of the LRRK2 inhibitor DNL201 for Parkinson\u2019s disease","volume":"14","author":"Jennings","year":"2022","journal-title":"Sci Transl Med"},{"key":"R171-20260305","doi-asserted-by":"crossref","first-page":"658","DOI":"10.1021\/ml300123a","article-title":"Brain penetrant LRRK2 inhibitor","volume":"3","author":"Choi","year":"2012","journal-title":"ACS Med Chem Lett"},{"key":"R172-20260305","doi-asserted-by":"crossref","first-page":"3555","DOI":"10.1042\/BCJ20210375","article-title":"Impact of Type II LRRK2 inhibitors on signaling and mitophagy","volume":"478","author":"Tasegian","year":"2021","journal-title":"Biochemical Journal"},{"key":"R173-20260305","doi-asserted-by":"crossref","first-page":"1814","DOI":"10.1001\/jama.2024.4783","article-title":"Ponatinib vs imatinib in frontline philadelphia chromosome-positive acute lymphoblastic leukemia: A randomized clinical trial","volume":"331","author":"Jabbour","year":"2024","journal-title":"Jama"},{"key":"R174-20260305","doi-asserted-by":"crossref","first-page":"267","DOI":"10.1161\/CIRCRESAHA.122.321504","article-title":"Ponatinib drives cardiotoxicity by S100A8\/A9-NLRP3-IL-1\u03b2 mediated Inflammation","volume":"132","author":"Tousif","year":"2023","journal-title":"Circ Res"},{"key":"R175-20260305","doi-asserted-by":"crossref","first-page":"519","DOI":"10.3324\/haematol.2016.152710","article-title":"Phase 1 dose-finding study of rebastinib (DCC-2036) in patients with relapsed chronic myeloid leukemia and acute myeloid leukemia","volume":"102","author":"Cortes","year":"2017","journal-title":"Haematologica"},{"key":"R176-20260305","doi-asserted-by":"crossref","first-page":"1864","DOI":"10.1016\/j.bmcl.2012.01.084","article-title":"Characterization of TAE684 as a potent LRRK2 kinase inhibitor","volume":"22","author":"Zhang","year":"2012","journal-title":"Bioorg Med Chem Lett"},{"key":"R177-20260305","doi-asserted-by":"crossref","first-page":"28","DOI":"10.1001\/jamaoncol.2024.5157","article-title":"Olverembatinib after failure of tyrosine kinase inhibitors, including ponatinib or asciminib: A phase 1b randomized clinical trial","volume":"11","author":"Jabbour","year":"2025","journal-title":"JAMA Oncol"},{"key":"R178-20260305","doi-asserted-by":"crossref","first-page":"113","DOI":"10.1186\/s13045-022-01334-z","article-title":"Olverembatinib (HQP1351), a well-tolerated and effective tyrosine kinase inhibitor for patients with T315I-mutated chronic myeloid leukemia: results of an open-label, multicenter phase 1\/2 trial","volume":"15","author":"Jiang","year":"2022","journal-title":"J Hematol Oncol"},{"key":"R179-20260305","doi-asserted-by":"crossref","first-page":"613","DOI":"10.1111\/bph.13395","article-title":"NVP-TAE684 reverses multidrug resistance (MDR) in human osteosarcoma by inhibiting P-glycoprotein (PGP1) function","volume":"173","author":"Ye","year":"2016","journal-title":"Br J Pharmacol"}],"container-title":["Chinese Medical Journal"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/journals.lww.com\/10.1097\/CM9.0000000000003989","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,3,5]],"date-time":"2026-03-05T05:01:04Z","timestamp":1772686864000},"score":1,"resource":{"primary":{"URL":"https:\/\/journals.lww.com\/10.1097\/CM9.0000000000003989"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,3,5]]},"references-count":179,"journal-issue":{"issue":"5","published-print":{"date-parts":[[2026]]}},"URL":"https:\/\/doi.org\/10.1097\/cm9.0000000000003989","relation":{},"ISSN":["0366-6999","2542-5641"],"issn-type":[{"value":"0366-6999","type":"print"},{"value":"2542-5641","type":"electronic"}],"subject":[],"published":{"date-parts":[[2026,3,5]]},"assertion":[{"value":"2025-02-27","name":"received","label":"Received","group":{"name":"publication_history","label":"Publication History"}}]}}